Lake Street Capital Lowers Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $13.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective trimmed by Lake Street Capital from $25.00 to $13.00 in a research report released on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the stock.

Several other brokerages have also recently issued reports on BIOX. Roth Mkm assumed coverage on shares of Bioceres Crop Solutions in a research note on Tuesday, July 2nd. They set a buy rating and a $15.00 price objective for the company. Canaccord Genuity Group reaffirmed a buy rating and set a $17.00 price objective on shares of Bioceres Crop Solutions in a research note on Friday, July 19th. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a strong-buy rating in a research note on Friday, July 19th. Finally, Roth Capital raised shares of Bioceres Crop Solutions to a strong-buy rating in a research note on Tuesday, July 2nd. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Bioceres Crop Solutions has a consensus rating of Buy and an average target price of $13.63.

Bioceres Crop Solutions Trading Down 0.5 %

Shares of Bioceres Crop Solutions stock opened at $8.56 on Wednesday. The firm has a 50-day simple moving average of $10.43 and a two-hundred day simple moving average of $11.42. The company has a market cap of $537.57 million, a P/E ratio of 856.00 and a beta of 0.49. Bioceres Crop Solutions has a fifty-two week low of $8.16 and a fifty-two week high of $14.05. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.83 and a current ratio of 1.28.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The company had revenue of $124.30 million for the quarter, compared to analyst estimates of $126.75 million. During the same quarter last year, the company earned ($0.06) EPS. As a group, equities analysts predict that Bioceres Crop Solutions will post 0.81 earnings per share for the current fiscal year.

Institutional Trading of Bioceres Crop Solutions

Several hedge funds have recently made changes to their positions in BIOX. Fourth Sail Capital LP grew its stake in shares of Bioceres Crop Solutions by 136.1% in the 1st quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock valued at $20,606,000 after buying an additional 938,282 shares during the period. Long Focus Capital Management LLC grew its stake in shares of Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after buying an additional 46,647 shares during the period. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in shares of Bioceres Crop Solutions in the 2nd quarter valued at approximately $472,000. Ping Capital Management Inc. acquired a new position in shares of Bioceres Crop Solutions in the 2nd quarter worth approximately $448,000. Finally, Lazard Asset Management LLC acquired a new position in shares of Bioceres Crop Solutions in the 1st quarter worth approximately $212,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.